Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
September 30, 2019
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
SUBSCRIBE: Print / Digital / eNewsletter
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
